IQVIA Holdings Inc. (IQV)
NYSE: IQV · Real-Time Price · USD
199.39
-0.86 (-0.43%)
Dec 27, 2024, 4:00 PM EST - Market closed
IQVIA Holdings Revenue
IQVIA Holdings had revenue of $3.90B in the quarter ending September 30, 2024, with 4.28% growth. This brings the company's revenue in the last twelve months to $15.32B, up 3.10% year-over-year. In the year 2023, IQVIA Holdings had annual revenue of $14.98B with 3.98% growth.
Revenue (ttm)
$15.32B
Revenue Growth
+3.10%
P/S Ratio
2.37
Revenue / Employee
$176,034
Employees
87,000
Market Cap
36.19B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 14.98B | 574.00M | 3.98% |
| Dec 31, 2022 | 14.41B | 536.00M | 3.86% |
| Dec 31, 2021 | 13.87B | 2.52B | 22.14% |
| Dec 31, 2020 | 11.36B | 271.00M | 2.44% |
| Dec 31, 2019 | 11.09B | 676.00M | 6.49% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Humana | 115.01B |
| Takeda Pharmaceutical | 31.73B |
| GE HealthCare Technologies | 19.56B |
| Alcon | 9.76B |
| Agilent Technologies | 6.51B |
| ResMed | 4.81B |
| DexCom | 3.95B |
| IDEXX Laboratories | 3.84B |
IQV News
- 4 days ago - Digital Health Tools are Expanding in Scope and Function to Aid Patient Diagnosis, Treatment and Monitoring, Says New Report from The IQVIA Institute - Business Wire
- 15 days ago - IQVIA Holdings: Share Price Disconnected From Growth Outlook - Seeking Alpha
- 7 weeks ago - IQVIA CFO Ron Bruehlman to Speak at the UBS Global Healthcare Conference on November 13, 2024 - Business Wire
- 2 months ago - IQVIA Holdings Inc. (IQV) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - IQVIA lowers annual revenue forecast amid trial delays - Reuters
- 2 months ago - IQVIA Reports Third-Quarter 2024 Results and Announces Investor Day - Business Wire
- 2 months ago - IQVIA to Announce Third-Quarter 2024 Results on October 31, 2024 - Business Wire
- 3 months ago - IQVIA Announces IQVIA AI Assistant, Powered by IQVIA Healthcare-grade AI™ - Business Wire